Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), has emerged as a significant advancement in diabetes technology over the last 50 years. Although commercial insulin ...
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens and Pumps - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Smart ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...
In diabetes management, insulin pumps represent transformative technological breakthroughs that provide individuals with a vital pathway to improved health and enhanced quality of life. These portable ...
MARKHAM, Ontario--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ ...
“The commercial availability of this new offering is a testament to our decade-long partnership with Dexcom and shared commitment to continued leadership in advancing AID systems,” said Mark Novara, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results